The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Weisblum Eric

Reporting owner CIK 0001569077 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Weisblum EricWeisblum EricWeisblum Eric · December 15, 2025 · Purchase · Common StockWeisblum Eric · December 15, 2025 · Purchase · Common StockWeisblum Eric · November 21, 2025 · Purchase · Common StockWeisblum Eric · November 20, 2025 · Purchase · Common StockWeisblum Eric · November 19, 2025 · Purchase · Common StockWeisblum Eric · November 18, 2025 · Purchase · Common StockNov 18, 2025Dec 15, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 15, 2025Silo Pharma, Inc.Common StockWeisblum EricPurchase
Dec 15, 2025Silo Pharma, Inc.Common StockWeisblum EricPurchase
Nov 21, 2025Silo Pharma, Inc.Common StockWeisblum EricPurchase
Nov 20, 2025Silo Pharma, Inc.Common StockWeisblum EricPurchase
Nov 19, 2025Silo Pharma, Inc.Common StockWeisblum EricPurchase
Nov 18, 2025Silo Pharma, Inc.Common StockWeisblum EricPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Silo Pharma, Inc.SILO · company listings
Weisblum EricChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P2,5000.42Value: 1,050Currency not specifiedView ↗
Trade: Silo Pharma, Inc.SILO · company listings
Weisblum EricChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P2,5000.41Value: 1,025Currency not specifiedView ↗
Trade: Silo Pharma, Inc.SILO · company listings
Weisblum EricChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P1,0000.365Value: 365Currency not specifiedView ↗
Trade: Silo Pharma, Inc.SILO · company listings
Weisblum EricChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P1,0000.37Value: 370Currency not specifiedView ↗
Trade: Silo Pharma, Inc.SILO · company listings
Weisblum EricChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P4,5000.405 *Value: 1,822.5Currency not specifiedView ↗
Trade: Silo Pharma, Inc.SILO · company listings
Weisblum EricChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P7,5000.4033 *Value: 3,024.75Currency not specifiedView ↗